Drugs / UWD-00B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06663046 | Jul 2025 → Dec 2027 | plasma cell myeloma, refractory plasma cell neoplasm | Wondercel Biotech (ShenZhen) | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UWD-00B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06663046 ↗ |
| Modality | Cell therapy | “universal BCMA CAR-T cells” NCT06663046 ↗ |